PREVALENCE OF MUTATIONS IN ELANE, GFI1, HAX1, SBDS, WAS, AND G6PC3 IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA

Por Xia, Jun, Bolyard, Audrey Anna, Rodger, Elin, Stein, Steve, Aprikyan, Andrew A., Dale, David C., Link, Daniel C.
Publicado em 2009

The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome

Por Dale, David C., Bolyard, Audrey Anna, Kelley, Merideth L., Westrup, Ernest C., Makaryan, Vahagn, Aprikyan, Andrew, Wood, Brent, Hsu, Frank J.
Publicado em 2011

Cyclic Neutropenia and Severe Congenital Neutropenia in Patients with a Shared ELANE Mutation and Paternal Haplotype: Evidence for Phenotype Determination by Modifying Genes

Por Newburger, Peter E., Pindyck, Talia N., Zhu, Zhiqing, Bolyard, Audrey Anna, Aprikyan, Andrew A. G., Dale, David C., Smith, Gary D., Boxer, Laurence A.
Publicado em 2010

Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia

Por Rosenberg, Philip S., Alter, Blanche P., Link, Daniel C., Stein, Steven, Rodger, Elin, Bolyard, Audrey A., Aprikyan, Andrew A., Bonilla, Mary A., Dror, Yigal, Kannourakis, George, Newburger, Peter E., Boxer, Laurence A., Dale, David C.
Publicado em 2007